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ABSTRACT 
Drug crystallization in transdermal drug delivery systems (TDDS) is a critical quality defect. 
The impact of drug load and hydration on the physical stability of polar (acrylic) drug-in-
adhesive (DIA) films was investigated with the objective to identify predictive formulation 
parameters with respect to drug solubility and long-term stability. Medicated acrylic films 
were prepared over a range of drug concentrations below and above saturation solubility; and 
were characterized by FTIR, differential scanning calorimetry (DSC), polarized microscopy 
and Dynamic Vapor Sorption (DVS) analysis. Physical stability of medicated films was 
monitored over four months under different storage conditions; and was dependent on 
solubility parameters, Gibbs free energy for drug phase transition from the amorphous to the 
crystalline state and relative humidity. DVS data, for assessing H-bonding capacity 
experimentally, was essential to predict physical stability at different humidities and was used 
together with Gibbs free energy change and the Hoffman equation to develop a new 
predictive thermodynamic model to estimate drug solubility and stability in DIA films taking 
into account relative humidity. 
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ABBREVIATIONS AND SYMBOLS 
a activity 
API active pharmaceutical ingredient 
ASA  acetylsalicylic acid 
DIA drug-in-adhesive 
DSC  differential scanning calorimetry 
DVS dynamic vapor sorption 
FTIR Fourier transform infrared 
spectroscopy 
GC gas chromatography 
HPLC high performance liquid 
chromatography 
IBU  ibuprofen 
K equilibrium constant 
PSA pressure sensitive adhesive 
RH Relative humidity 
SAA  salicylic acid 
T Temperature 
TDDS transdermal drug delivery systems 
Tg Glass transition temperature 
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x (or X) molar fraction 
δ solubility parameter 
ΔGH Gibbs free energy of hydrogen 
bonding 
ΔGm Gibbs free energy of mixing 
ΔGv Change of Gibbs free energy upon 
crystallization 
ΔHf (or ΔHfus)  Enthalpy of fusion 
ϕ volume fraction 
χ Flory-Huggins interaction 
parameter 
ωi mass fraction of i
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INTRODUCTION 
Transdermal Drug Delivery Systems (TDDS), or transdermal patches, are dosage forms intended 
for delivering a drug across the skin into the systemic circulation. TDDS can have drug-specific 
benefits over conventional oral dosage forms as they by-pass the hepatic “first pass” metabolism 
and are devoid of gastro-intestinal side effects. They can also provide continuous drug delivery 
and stable plasma concentrations over an extended application time. Patches for passive drug 
delivery can be classified in four main types: drug-in-adhesive (DIA), drug reservoir membrane 
modulated systems, microreservoir systems as well as non-self-adhesive polymer matrices1,2.  
Drug release from passive diffusion-controlled TDDS depends on the chemical drug potential; 
however, stability issues can occur over time due to crystallization of the active pharmaceutical 
ingredient API3. Such change of the physical drug state is considered as a critical quality defect 
that may alter the adhesion-cohesion balance of the system, and more particularly drug release 
performance of the TDDS, thus leading to potential patient safety issues. Stable DIA acrylic films 
formulated with APIs possessing ideal physicochemical properties for passive skin diffusion are 
marketed already e.g. Nitro-Dur® or Minitran® containing nitroglycerin which has a melting point 
of 14°C and is present in liquid state at storage temperature. In contrast, APIs exhibiting a melting 
point above storage temperature e.g. estradiol (178°C), have a ‘natural’ tendency to recrystallize 
within the formulation if present above saturation solubility; as a consequence they are often 
formulated in matrix or reservoir patch designs using stabilisers in addition. 
Three aromatic carboxylic acids; ibuprofen (IBU), salicylic acid (SAA) and acetylsalicylic acid 
(ASA) were formulated to DIA films using acrylic pressure sensitive adhesive (PSA). Acrylic 
PSA is polar, and may allow drug stabilization via H-bonding inter alia.  
The aim of this work was therefore to define boundary conditions for drug crystallization 
inhibition in acrylic PSA using the Hoffman equation and assuming that Gibbs free energy change 
for the phase transition from the amorphous to the crystalline state (∆) is equal or higher 
compared to Gibbs free energy change of mixing i.e. the Gibbs free energy of H-bonding4.  
Different approaches for the prediction of drug crystallization in polymer matrix have already 
been described for solid dispersion applications only, based on thermodynamic5–10, kinetic11 or a 
combination of thermodynamic and kinetic principles12. Typical semi-empirical thermodynamic 
approaches consisted in using thermal analysis (recrystallization of supersaturated solid 
dispersions or melting point depression methods)6–8, water sorption data8,10 or solubility of API in 
low molecular weight analogue of polymer7,8, to apply either Flory-Huggins or the regular 
solution theory, which however do not allow for hydrogen bonding interactions. Alternatively, 
Prudic et al.9 applied a computational thermodynamic model (PC-SAFT) to solve the water vapor-
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liquid and API solid-liquid equilibria to predict the impact of water sorption and API 
crystallization on API (indomethacin and naproxen) and polymer (PVP and poly(vinyl 
pyrrolidone-co-vinyl acetate)) solid dispersions. Mistry and Suryanarayanan11 determined the 
crystallization times of solid dispersion using crystallization time of API and coupled relaxation 
times of saturated solid dispersions measured experimentally at different temperatures, but without 
evaluating the impact of humidity. Duarte et al.12 used a computational method to estimate the 
microstructure of API-polymer systems, based on thermodynamic (Flory-Huggins theory), kinetic 
(Fick’s second law of diffusion) and manufacturing (solvent evaporation) considerations to rank 
the polymers according to their miscibility with the drug (itraconazole). All the above models 
were developed for drug-hydrophilic polymer solid dispersions. There is currently no predictive 
model for the stability of drug-adhesive polymers, however due to the polar nature of the acrylic 
adhesive we could describe acrylic DIA films as drug-hydrophilic polymer solid dispersion 
systems. 
Our approach takes into account the effect of drug load and relative humidity (derived 
experimentally by measuring DVS data) resulting in the development of a novel and simple 
predictive equation which considers both the effect of H-bonding and the effect of hydration on 
the physical stability of DIA films. This work is complementary to our paper describing the 
development of a predictive model for the estimation of stabilizer concentration in non-polar 
pressure sensitive adhesives13. 
 
MATERIALS AND METHODS 
Materials 
DuroTak 87-4287 was supplied by Henkel (Düsseldorf, Germany). SAA and ASA were acquired 
from Sigma-Aldrich (St Louis, MI, USA) and IBU from Knoll Pharmaceuticals (Nottingham, 
UK). HPLC grade ethyl acetate was purchased from Fisher Scientific (Fair Lawn, New Jersey, 
USA). Release liner Scotchpak 9755 and backing liner Scotchpak 9735 were supplied by 3M (St 
Paul, USA). 
 
Methods 
Estimation of solubility parameters 
Solubility parameters δ of drugs and acrylic PSA were determined using Synthia software 
(Material Studio, Accelry’s). This software allows the calculation of δ after input of the repeat 
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units of a polymer, thus, drug structures were each entered as monomer units by setting a tail atom 
and a head one. Acrylic adhesives are prepared from a mixture of different monomers (55-75% of 
2-ethylhexyl acrylate, 2-6% of 2-hydroxyethylacrylate and 20-40% vinylacetate) but the exact 
composition is not disclosed by the manufacturer. Solubility parameter of acrylic adhesive was 
approximated by the solubility parameter of the main monomer, 2-ethylhexyl acrylate. 
 
Calculation of drug solubility in adhesive 
An estimate of equilibrium solute solubility was calculated, using the limiting form (2) of the 
Flory equation (1), for IBU, SAA and ASA14,15: 
(1)  ∆ =  	ln  + 1 −  1 − ) ! + "1 − )
#$% ! & 
Where ∆ is the Gibbs free energy of mixing of the drug and the polymer, " is the Flory-
Huggins interaction parameter between the drug and the polymer, is the volume fraction of the 
drug (which can be approximated by the mass fraction of the drug),  and  are the molar 
volumes of the drug and the polymer respectively (in cm3.mol-1), T the temperature (298 K) and R 
the gas constant (8.314 J. K-1.mol-1). 
Due to the important difference of molar volume of a small molecule (drug) compared to a 
polymer, it can be considered that '(') ≪ 1 and  ≪ 1 (diluted solution). At equilibrium, ∆ = 0  
So,  at equilibrium can be approximated by: 
(2)   = exp−1 + ") 
With " calculated using an extension of the Hildebrand-Scatchard theory of regular solutions16: 
(3)  " = 0.34 +  × 3 − 3) 
where 3 is the solubility parameter of the drug and 3 of the polymer (in MPa1/2).  
This equation is valid only in the case where there are no specific interactions between the drug 
and the polymer. 
To evaluate the impact of physical dispersive forces on the free energy of the super-cooled drug 
liquid in the case of DIA systems, the regular solution equation17 can be applied. For a mixture of 
drug and polymer, the activity coefficient of the drug can be estimated by using the solubility 
parameters of the PSA and the drug (3 and 3, respectively) from the Scatchard-Hildebrand 
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equation (4)17. However, this theory has been developed for non-polar compounds, when the 
interactions are symmetrical and the molecules are distributed randomly: 
(4)  456 7⁄ ) =  × 3 − 3) 
Where 6 is the drug activity, 7 is the drug molar fraction,  is the drug molar volume and  
the polymer volume fraction and T the temperature (K). Assuming the heat capacity of the drug is 
constant, the drug activity can be approximated by: 
(5)  456 = − ∆:;<= − )  
Where ∆:;<= is the enthalpy of fusion (J.mol-1) of the drug and  its melting temperature (K). 
Then, the combination of (4) and (5) gives the regular solution equation: 
(6)  457) = − ∆:;<= − ) −  × 3 − 3) 
The drug mass fraction solubility in PSA can be estimated (from (6)) by assuming that the drug 
mass fraction solubility can be approximated by 7 and that  ≈ 1. 
 
Estimation of the driving force for drug recrystallization (Hoffman equation) 
The prediction of drug solubility at equilibrium in acrylic adhesive was calculated based on the 
driving force for drug recrystallization from the Hoffman equation18, i.e. the chemical energy 
gained by the phase transition from the amorphous to the crystalline state: 
(7)  ∆ ≈ − ∆:;<= − )  
Where ∆ is the change in Gibbs free energy upon crystallization (J.mol-1), ∆:;<= the enthalpy of 
fusion (J.mol-1),  the melting temperature (K) and T the temperature (K). 
 
2.2.4 Determination of solid content of liquid adhesives 
The solid content of liquid adhesive was measured gravimetrically according to Wolff et al15. 
Results were verified by examination of residual solvent using Headspace Gas Chromatography as 
described in the following section. The mean value of solid content was subsequently used for the 
calculation of the required amount of liquid adhesive for each target drug load in medicated films. 
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Residual solvent analysis  
Residual solvent in dry adhesive and drug-in-adhesive (DIA) films was determined by Headspace 
Gas Chromatography (GC) (Agilent Technologies 7890A, Santa Clara, CA, USA). Ethyl acetate is 
a class 3 solvent and its overall concentration in pharmaceutical products should be less than 5000 
ppm (or 0.5% (w/w))19. 
Calibration curves were prepared using five solutions of ethanol and ethyl acetate in internal 
standard (toluene) for the quantification of solvent residues in dry adhesive and DIA films. 
20cm2 of dried three-layer system samples (backing membrane/adhesive layer/release liner) (n = 
3) were punched and the release liner was removed. The remaining film was introduced into a 
20ml headspace vial containing 5ml of internal standard and the vial was capped immediately. A 
blank of internal standard was injected at the start of each run. 
A DB-624 (30 x 0.53mm x 3.0µm) GC column was used with helium gas as the carrier (constant 
flow of 35cm/min) with 3.5 psi gas pressure. The United State Pharmacopoeial method, USP 467, 
for the Headspace analysis of organic volatile impurities was applied20. 
Total solvent residues were less than 0.2 % (w/w) in every sample. 
 
Coating and drying of DIA films 
The release liner (3M Scotchpak 9755) was cut to the required length to fit the Erichsen Model 
509/1 film coater (Hemer-Sundwig, Germany) with the release coating side facing up. The 
solutions were coated onto the release liner sheet. The knife blade was set to a height of 250 µm 
and the speed of the blade was set to 6 mm/s. The coated solutions were then dried using a 
universal oven (Memmert Model UNE 400, Schwachbach, Germany) at controlled temperature 
and the dried films were laminated with a 3M Scotchpak 9735 backing liner. Drying conditions 
were adjusted so that residual solvents did not exceed 0.2% (w/w). Optimized drying conditions 
were found to be 15 min at 50°C. 
 
Preparation of DIA-type films 
DIA-type films were prepared at different drug concentrations (detailed in Table 1), in order to get 
an estimate of the drug saturation solubility in the dry adhesive. 
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An accurately weighed mass of drug was introduced in a tared container. An accurate mass of 
liquid adhesive was then added in the same container, which was quickly capped to minimize 
solvent evaporation and the mixture was stirred at about 150 rpm overnight, using an overhead 
stirrer (IKA, Staufen, Germany). 
The solution was then coated and dried as described previously and three films were prepared per 
solution. Three 20 cm2-samples were subsequently punched per film and analyzed using 
headspace gas chromatography to verify that solvent residues did not exceed 0.2%w/w. The mean 
coating weight (n = 3 or 4) and film thickness (n = 5) were measured per film (intra-film mean) 
and then averaged (inter-film mean, n = 3). 
 
Table 1. Compositions of DIA films (dried for 15 min at 50°C). Mean film thicknesses ranged 
from 95 to 105 μm (film coating weights from 7.3 to 8.5 mg.cm-2). 
 
 
Differential Scanning Calorimetry (DSC)  
Examination of the thermal behavior of pure drugs and adhesive films was carried out with a DSC 
Q1000 (TA Instrument, USA) purged with dry nitrogen (50 ml/min). Calibration of the instrument 
was established using indium standard. 
Samples were accurately weighed using a microbalance (Mettler MT5, Mettler-Toledo, 
Greifensee, Switzerland) and introduced into aluminum hermetic pans and lids. Standard 
heat/cool/heat cycles (heating and cooling rate of 5°C/min or 10°C/min) were performed in 
triplicate (see Table 2), with cycle 1 corresponding to the first heat, cycle 2 the cooling and cycle 
3, the second heat. Melting points and enthalpies of fusion were recorded from the melting 
endotherms of the first heat, whereas glass transition temperatures (Tg) were recorded from the 
second heat.  
Table 2. DSC tests temperatures. 
 
Polarized Microscopy 
Medicated films were observed under a microscope (Olympus BH-2, Olympus Corporation, 
Tokyo, Japan) fitted with a 10× magnification lens, a camera (AxioCam, MRc, Carl Zeiss, UK) 
and AxioVision vs4.4 software. Polarized light was used in order to determine whether the 
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particles observed were crystalline. The scale of the microscope was calibrated for each 
magnification using graticules of 1mm. 
 
Dynamic Vapor Sorption (DVS) 
Dynamic vapor sorption experiments were performed on pure compounds and drug-in-acrylic 
films, using a DVS Advantage 1 instrument (Surface Measurement Systems UK Ltd., London, 
UK) equipped with a recording ultra-microbalance exhibiting a mass resolution of 0.1µg. A 
quantity of sample of typically 8 to 12mg was placed into a tared aluminium pan, which was 
placed on the DVS pan. The temperature was maintained constant at 25 ± 0.1°C and the sample 
was exposed to 0.00 partial pressure (in order to record its dry mass) and then to the following 
water vapor partial pressure profiles: 0.20, 0.40, 0.60, 0.80 and 0.90 p/p0. The partial pressure was 
then decreased in an identical manner to 0.00 p/p0. Each step lasted until the mass variation over 
time of the sample was lower than 0.002%.min-1, so that the sample mass reached equilibrium. 
The sorption isotherms were calculated from the equilibrium mass values at each partial pressure, 
using the change in mass with respect to the dry mass. 
 
Exploratory stability studies 
Samples of 20cm2 each (n = 3) were punched from fresh binary mixture layers and DIA films. 
Each one was stored at a different condition: 
- at 25.0 ± 0.6°C and at 70 ± 1 % RH into a monitored oven (c1), 
- at ambient temperature (21 ± 2°C) and at low RH (0.9 ± 0.7%) into a cabinet (in the 
presence of phosphorus pentoxide) (c2), 
- at ambient (21 ± 2°C) temperature and ambient RH (37 ± 7%) (c3). 
Samples were observed at regular intervals using polarized microscopy to detect any 
crystallization. DSC analyses were also performed to confirm the microscopy results. 
 
Statistical analysis 
T-tests and one way analysis of variance (ANOVA) were used to analyze DVS data using SPSS 
version 18 (SPSS UK Ltd, IBM, Woking, UK). Post hoc analysis was carried out with the Scheffe 
method and a level of significance of 95% (p = 0.05). When criteria of normality and homogeneity 
were not met, non-parametric tests were performed (Mann-Whitney). 
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RESULTS AND DISCUSSION 
Exploratory stability studies 
Results of the stability studies (Table 3) carried on drug-in-acrylic adhesive films allowed 
experimental approximation of drug solubility in dry acrylic (Table 4). Thermal properties of pure 
drugs and DIA films were also determined using DSC (Table 5). The Tg values of the DIA films 
were lower than the Tg values of the pure acrylic, indicative of the plasticizing effect of the drug. 
Table 3. Physical stability of drug-in-acrylic films at different storage conditions 
 
    
IBU-in-acrylic films at 20%(w/w) exhibited edge effect depending on storage conditions (edge 
effect was more prevalent at high storage humidity). Instability was confirmed by DSC, which 
showed, after storage, a melting endotherm corresponding to crystalline ibuprofen. The acrylic 
film containing 17%(w/w) of IBU remained clear and stable. Thus saturation solubility of IBU in 
acrylic adhesive was between 17% and 20%(w/w).  
SAA films remained crystal-free at 7%(w/w) but not at 13.5%(w/w) loading. ASA films were 
stable at drug load of 4%(w/w) but exhibited crystallization at 7%(w/w), consistent with DSC 
results. Hence, solubility of SAA in acrylic films was between 7% and 13.5%(w/w) and solubility 
of ASA in acrylic films was between 4% and 7%(w/w). 
Solubility parameter of acrylic adhesive was determined using the solubility parameters of 2-
ethylhexylacrylate to be 19 MPa1/2. The prediction of drug solubility in acrylic adhesive estimated 
using the previously disclosed Flory-Huggins equation (Equation 2) gave results in partial 
agreement with experimental observations (Table 4); i.e. a good fit was observed for IBU and 
ASA whereas solubility calculations for SAA were not in agreement with experimental data. 
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Table 4. Comparison of theoretical and experimental drug solubility in acrylic PSA at 25 °C. 
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Table 5. Thermal properties of pure compounds, unsaturated and saturated fresh DIA films (determined experimentally) 
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The observed deviations in the case of SAA may be explained by the fact that SAA formed strong 
dimers, which impacted its solubility parameter22. The solubility parameter of SAA dimer was 
actually lower, 22.1 MPa1/2 23,24, as the dimer was less available for hydrogen bonding, leading to a 
smaller difference in solubility parameters between drug and PSA and thus higher predicted 
saturation solubility. As neither of the calculated solubilities of monomeric and dimeric SAA 
using the Flory-Huggins equation were in agreement with the experimental results, it could be 
postulated that there was a mixture of monomer and dimer SAA in the DIA systems.  
In addition, the regular solution theory was valid for non-polar compounds and the mass fraction 
solubility was actually approximated by the molar fraction leading to an uncertainty on solubility 
parameter calculation. Prediction of drug solubility in pure adhesives was done using the limiting 
form of Flory-Huggins equation (and the regular solution equation) assuming that they did not 
interact specifically (e.g. acid-base reaction or defined complex formation) with the drugs25. 
Acrylic adhesive holds polar moieties and therefore, an alternative approach was developed, 
taking into account dipole-dipole or hydrogen bonding interactions between the drugs and acrylic 
adhesive. 
 
Predictive model development and implementation  
The entropic term and physical forces terms accounting for non-hydrogen bonding solubility 
parameters could be neglected in the modified Flory-Huggins equation14,26 in the investigated 
formulations:  
(8)  ∆ = ?@ ln  + @ ln ABCCCCCCDCCCCCCE
F ! F
+ "BCDCE#G= !$% ;!F= F  HIJK L) + ∆HM
HIJK L
 
 
∆Gm is the Gibbs free energy of mixing of the drug and the polymer, " is the interaction parameter 
between the drug and the polymer,  is the volume fraction of the drug (which may be 
approximated by the mass fraction of the drug) and  of the polymer, @ and @ the molecular 
weights of the drug and the polymer respectively, T the temperature (298 K), R the gas constant 
(8.314 J. K-1.mol-1) and ∆H the Gibbs free energy of hydrogen bonding between the drug and the 
polymer (generally favourable to mixing). This term ∆H does not take into account the physical 
interaction contribution (included in second term). The first term is for the changes of entropy 
(entropy of disorientation and localization) upon mixing. The second term is an enthalpic term 
related to non-hydrogen-bonding interactions between the polymer and the solute, which are 
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defined by the usual interaction parameter ". The derivation of (8) does not involve more 
assumptions than the usual Flory-Huggins equation and polymer lattice theory and includes the 
changes in entropy and enthalpy of hydrogen bond formation upon mixing of a polymer and a 
solute that interact via H-bonding.  
DVS data of pure APIs and unsaturated drug-in-acrylic films are shown in Figure 2a and b, 
respectively. Fig 2b shows that pure acrylic films absorbed less moisture than drug loaded films (p 
= 0.025). Considering that water uptake by pure APIs was negligible, the increase in water uptake 
by the drug loaded acrylic films could be due to the different microstructure between unmedicated 
and medicated acrylic films; incorporation of drug molecules resulted in ‘breakage’ of intra-
molecular hydrogen bonds between polymer chains of the adhesive, as a result of drug/acrylic 
polymer H-bonding interaction, leading to an increase in the number of sites (of polymer) 
available for binding with water. As such, the medicated film microstructure consisted of 
additional polar groups from the acrylic polymer, compared to the unmedicated film, available for 
water absorption. During the DVS measurements, H2O is replacing drug molecules bound via 
hydrogen bonding to the polymer and therefore the DVS data is an indicator for drug-polymer 
interaction via H-bonding. This replacement of drug molecules by water molecules also explains 
the “hydration effect” in DIA films, which enables drug release upon skin application. 
Drug/acrylic H-bonding can retain the stability of the DIA film during storage; when the film is 
applied to the skin, moisture uptake from the stratum corneum breaks the drug/polymer H-bonds 
enabling the free unbound drug molecules to diffuse into the stratum corneum. However this 
phenomenon also reiterates the need for appropriate packaging and storage of the DIA films at low 
humidity conditions, in order to retain the physical stability of the film.  
Water sorption of saturated drug-in-acrylic films was higher compared to their respective 
unsaturated drug-in-acrylic film especially for SAA and ASA (p = 0.016), (Figure 2b(i) and b(ii)). 
This difference in water sorption between saturated and unsaturated DIA films correlates well and 
can be explained by the different Tg values of these films (Table 5); saturated films had lower Tg 
value compared to their unsaturated counterpart, indicating that an increase in drug concentration 
in the film had a more prominent plasticizing effect, leading to increased molecular mobility in the 
film and increased water sorption. Whereas the similar Tg value for saturated (20%(w/w)) and 
unsaturated (17%(w/w)) ibuprofen-in-acrylic films correlated with their similar water sorption, 
indicating that the 17%(w/w) film was already saturated. 
All unsaturated drug-loaded acrylic films showed similar water uptake values, independent of drug 
type, whereas saturated films showed variable water uptake (Figures 2b(i) and b(ii)). This latter 
variability can be correlated with the Tg data and thus can be attributed to variability in the 
16 
 
plasticizing effect and also to variability in intramolecular H-bonding among drug molecules; for 
example stronger H-bonding interaction between SAA molecules increased the availability of 
acrylic polar groups for water binding and combined with an increased plasticizing effect, resulted 
in higher water sorption compared to saturated films containing IBU or ASA. 
 
The drug portion which was subject to H-bonding with the functional groups of the acrylic 
adhesive was in equilibrium with the portion of free dissolved (non-interacting, non-amorphous) 
drug.  
 
The new predictive model is based on Gibbs free energy change for H-bonding ∆H), which can 
be expressed by: 
(9)  −∆H = − ln N 
With  
(10)  N = OPOQ = RPRQ 
Where OP and OQ are the mole fractions of free drug and bound drug, respectively and RP and RQ 
the mass fractions, i.e. OP + OQ = 1 (or OP = 1 − OQ). 
Consequently,  
(11)  OP = N1 + N 
Also, it can be approximated that 
(12)  ∆H ≈ ∆ 
To get a stable semi-solid drug solution, Gibbs free energy change for the phase transition from 
the amorphous to the crystalline state (∆) has to be equal or higher (actual values) compared to 
Gibbs free energy change of mixing (or Gibbs free energy of H-bonding). Consequently, at 
equilibrium: 
(13)  ∆ ≈ ∆H 
And by combining (9) and (12) 
(14) N ≈ exp ∆  
By combining (11) and (14), it can be deduced that: 
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(15) OP = exp S∆ T1 + exp S∆ T 
This means that, for a drug/acrylic polymer mixture the fraction 1-OP needs to be stabilised by 
hydrogen bonding. A fraction of 1-OP of binding sites is therefore required. In other words, OP (or RP) represents the maximum fraction of free drug that is allowed to get a stable system 
characterized by a reduced chemical potential of the drug due to drug-polymer interactions via 
hydrogen bonding. Accordingly, OP (or RP) can be taken as an estimate for drug solubility in 
tested systems provided that number of interacting functional groups is sufficient for hydrogen 
bonding interactions.  
A modified correction factor for estimating the impact of water on the formulation was introduced, 
as hydrogen bonding depends on the number of polymer segments available for drugs with 
hydrophilic functional groups. This number U$! decreases with hydration (increase of RH) and 
was calculated according to equation (16). The mole number of water (5H)V in mol/100g of 
sample) was calculated from water sorption isotherms results of drug-loaded adhesive films: 
(16)  U$!:) = 5K<L5K<L + 5H)V 
Where 5K<L is the total molar quantity of drug, in mol/100g of sample. 
By multiplying this factor with the calculated free drug molar fraction, estimation for stable 
unbound drug concentrations, the mass fraction solubility, at different relative humidity (RH) 
values is possible: 
(17) R= !):) = RP × U$! × 100 
The correction factors facr are listed in Table 6. Table 7 shows the predicted drug solubility in 
acrylic adhesive after correction, in comparison to experimental data. According to Table 7, the 
solubility of the tested carboxylic acids is decreasing with increasing relative humidity. The ratio 
between the tested drug concentration and the saturation solubility is shown in Figure 4. Values 
greater than 1 direct to an unstable or metastable physical state. The predicted solubility was in 
good agreement with physical stability observed for high and reduced drug loads. 
 
Table 6. Correction factors facr for drug-in-acrylic films (drug loading % (w/w) shown next to 
each drug) obtained from water sorption data at (25°C). 
 
Table 7. Predicted drug solubility at different relative humidities (RH) (in % (w/w)) at 25 °C. 
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Experimental data and predicted drug solubility in acrylic adhesive were compared (Table 8): 
Tested higher drug loads were not physically stable, in agreement with the prediction, due to the 
reduction of solubility caused by the hydration effect. To investigate in more detail the impact of 
water absorption on drug solubility, DVS studies and long-term physical stability tests were 
performed on samples with lower drug loads. As predicted, samples of low drug loads were shown 
to be stable under test conditions (up to 70% RH). In conclusion, this is a reliable mathematical 
approach which enables the prediction of a stable drug load and long-term stability of drug-in-
acrylic films. 
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Table 8. Stability of acrylic-type test samples manufactured with Duro-Tak 87-4287 compared to predicted solubility 
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There was a good agreement between experimental and calculated results using the DVS 
data. Besides, the predicted solubility values using water sorption data (equation (17)) were 
closer to experimental results than predicted solubilities using the limiting form of Flory-
Huggins equation, especially in the case of SAA (due to the imprecision on the different 
solubility parameters of the monomer and dimer forms of the drug). The Flory-Huggins 
equation allowed the prediction of drug solubility based on solubility parameters and 
appropriate estimate of the interaction parameter χ. However it does not take into account the 
impact of polymorphism, contrary to regular solution equation and the estimation of drug 
solubility using the above approach which is based on hydrogen interactions and the Hoffman 
equation with respect to DVS data. Using this latter approach, the free energy change for 
crystallization was compared with the Gibbs free energy of mixing. The observed impact of 
hydration on saturation solubility confirmed that Gibbs free energy of hydrogen bonding 
largely governed the change of Gibbs free energy of mixing in the tested acrylic adhesive. 
Flory-Huggins theory has also been used for ternary mixtures of API-polymer-water to 
determine the impact of RH on miscibility8,10, which only allowed a qualitative evaluation. 
Moreover, application of this equation from data generated by the melting point depression 
method led to imprecise results (low correlation coefficient8) which were dependent on 
experimental heating rate as shown by Knopp et al.5. Rask et al.7 also emphasized that 
solubility measurements using recrystallization of supersaturated amorphous dispersions 
should be considered with caution.  
A different approach was employed for solid dispersions intended for oral formulation by 
Prudic et al.9, which involved modelling and thermal analysis. The authors used a 
thermodynamic model, Perturbed Chain-Statistical Association Fluid Theory, which 
determined the residual Helmholtz energy by describing a molecule as a chain of segments 
and experimental data on binary systems to solve simultaneously vapor-liquid equilibrium of 
water (moisture) and liquid-solid equilibrium of API (amorphous/crystalline). Similarly to 
our model, it considered hydrogen bonding interactions and the impact of relative humidity, 
but required a more complicated implementation as opposed to our approach. 
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CONCLUSION 
For the tested DIA acrylic systems, experimental results were compared to the solubility 
calculated using the limited form of Flory-Huggins equation, as well as using the regular 
solution equation which considers both the heat of fusion and the solubility parameter 
difference. Assuming that the drug was able to interact via hydrogen bonding with the acrylic 
adhesive, a thermodynamic approach was developed for DIA systems based on the Hoffman 
equation to estimate the drug saturation solubility and stability from DSC and DVS data, 
hence avoiding the use of solubility parameters. Water sorption studies on pure drugs, pure 
acrylic PSA and on acrylic DIA showed that acrylic DIA samples absorbed a greater amount 
of water than the pure acrylic PSA. The resulting calculated drug solubility in acrylics 
appeared to be in a good agreement with the experimental stability results. 
 WX YZ[[)\]) = W^ × _`[ab_`[ab + _]cd × eff 
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FIGURE LEGENDS 
Figure 1. Chemical structure of selected drugs and acrylic PSA (polyacrylate). 
 
Figure 2. a) Water sorption isotherms of pure drugs (n=3); b) Water sorption isotherms of (i) 
unsaturated, and (ii) saturated drug-in-acrylic films in comparison to the pure adhesive (n=3) 
 
Figure 3. Different states of the drug in the acrylic matrix. 
 
Figure 4. Plot of the ratio between tested concentration and calculated solubility (depending 
on relative humidity, at 25°C). Values lower than 1 indicate unsaturation, greater than 1 
saturation. 
 
LEGEND FOR THE GRAPHICAL ABSTRACT 
Drug solubility in the acrylic matrix. 
 
